Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Ahead of Print

Recurrent squamous cell carcinoma of the skin treated with immunotherapy

1 Department of Medical Oncology, HCG-SC, Bengaluru, Karnataka, India
2 Department of Radiation Oncology, HCG-SC, Bengaluru, Karnataka, India
3 Department of Clinical Oncology, Harare Oncology Centre, Harare, Zimbabwe
4 Department of Histopathology, HCG-SC, Bengaluru, Karnataka, India

Correspondence Address:
BJ Srinivasa,
Department of Medical Oncology, HCG-SC, Bengaluru - 560 027, Karnataka
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jcrt.JCRT_1018_20

Squamous cell carcinoma (SCC) has a good prognosis, while metastatic tumors have aggressive behavior. Immunotherapy has become a standard line of treatment in metastatic cancers; pembrolizumab has shown promising results and improved quality of life in recurrent and metastatic cancers. We report a case of recurrent SCC of the skin with extensive disease and a known case of human immunodeficiency virus. He completed standard lines of treatment and currently on immunotherapy. After 3 cycles of immunotherapy plus chemotherapy, he got a complete metabolic response. Our experience showed palliative benefits and increased quality of life.

Print this article
  Search Pubmed for
    -  Srinivasa B J
    -  Sridhar P S
    -  Lalkota BP
    -  Tsikai N
    -  Niyati P S
    -  Shah M
    -  Anuradha S
    -  Roopesh R
    -  Ramaswamy V
    -  Naik R
    -  Ajaikumar B S
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded1    

Recommend this journal